Astrocyte‐specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of Neurology

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.10283PMID 12205640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation

  2002cited by this paper
• Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/− cells

  2002cited by this paper
• Astrocytes Give Rise to New Neurons in the Adult Mammalian Hippocampus

  2001cited by this paper
• Nestin-EGFP transgenic mice: visualization of the self-renewal and multipotency of CNS stem cells.

  2001cited by this paper
• A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice

  2001cited by this paper
• CNS synaptogenesis promoted by glia-derived cholesterol.

  2001cited by this paper
• The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination

  2000cited by this paper
• Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues

  2000cited by this paper
• The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

  2000cited by this paper
• The TSC1 gene product, hamartin, negatively regulates cell proliferation.

  2000cited by this paper
• Dual Fluorescent In Situ Hybridization and Immunohistochemical Detection with Tyramide Signal Amplification

  2000cited by this paper
• Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.

  1999cited by this paper
• Characterization of the Cytosolic Tuberin-Hamartin Complex

  1999cited by this paper
• Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

  1999cited by this paper
• Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.

  1998cited by this paper
• Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.

  1998cited by this paper
• Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria

  1998cited by this paper
• The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis*

  1997cited by this paper
• Evidence of abnormal differentiation in giant cells of tuberous sclerosis.

  1997cited by this paper
• Alterations in the rap1 signaling pathway are common in human gliomas

  1997cited by this paper
• Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

  1997cited by this paper
• Cortical Tuber Count: A Biomarker Indicating Neurologic Severity of Tuberous Sclerosis Complex

  1997cited by this paper
• Synaptic efficacy enhanced by glial cells in vitro.

  1997cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.

  1996cited by this paper
• New views on synapse-glia interactions.

  1996cited by this paper
• The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

  1996cited by this paper
• Synergistic effect of intrastriatal co‐administration of L‐NAME and quinolinic acid

  1995cited by this paper
• Role of sodium and potassium ions in regulation of glucose metabolism in cultured astroglia.

  1995cited by this paper
• Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*)

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Expression of the neurofibromatosis 1 (NF1) gene in reactive astrocytes in vitro

  1995cited by this paper
• Evidence for glutamate-mediated activation of hippocampal neurons by glial calcium waves.

  1995cited by this paper
• Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina

  1995cited by this paper
• Tuberous sclerosis.

  1994cited by this paper
• GFAP promoter directs astrocyte-specific expression in transgenic mice

  1994cited by this paper
• Glial cells transform glucose to alanine, which fuels the neurons in the honeybee retina

  1994cited by this paper
• Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS.

  1994cited by this paper
• Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13

  1994cited by this paper
• Identification and characterization of the tuberous sclerosis gene on chromosome 16

  1993cited by this paper
• Studies on rat sympathetic neurons developing in cell culture. II. Synaptic mechanisms.

  1978cited by this paper
• Studies on rat sympathetic neurons developing in cell culture. III. Cholinergic transmission.

  1978cited by this paper

• Deeper neuronal and glial proteomic insights using an optimized pipeline for proximity labeling proteomics

  2026cites this paper
• Bidirectional sleep-seizure interactions and orexin in a mouse model of tuberous sclerosis complex-related epilepsy.

  2026cites this paper
• Loss of Tsc2 in Neonatal V-SVZ Neural Stem Cells Causes Rare Malformations

  2026cites this paper
• Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory

  2025cites this paper
• Developmental mechanisms underlying pediatric epilepsy

  2025cites this paper
• AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth.

  2025cites this paper
• Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome

  2025cites this paper
• A missense variant in DEPDC5 resulted in abnormal morphology and increased seizure susceptibility and mortality through regulating mTOR signaling.

  2025cites this paper
• mTOR pathway gene knockout results in mTOR-dependent cellular aggregation

  2025cites this paper
• Neuroglia pathology in genetic and epigenetic disorders of the central nervous system.

  2025cites this paper
• AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1

  2025cites this paper
• The critical role of the proto-oncogene c-Kit in TSC renal cystogenesis

  2025cites this paper
• Current and emerging tools for studying animal models of sleep and autism.

  2025cites this paper
• Using cortical organoids to understand the pathogenesis of malformations of cortical development

  2025cites this paper
• AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth

  2024cites this paper
• Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome

  2024cites this paper
• The role of TSC1 and TSC2 proteins in neuronal axons

  2024cites this paper
• Tcf4 Deficiency Causes Recurrent Seizures in Mice

  2024cites this paper
• Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit

  2024cites this paper
• Downregulation of nuclear receptor-binding SET domain protein 1 induces proinflammatory cytokine expression via mitogen-activated protein kinase pathways in U87MG cells.

  2024cites this paper
• WONOEP appraisal: The role of glial cells in focal malformations associated with early onset epilepsies

  2024cites this paper
• Mechanosensitive mTORC1 signaling maintains lymphatic valves

  2023cites this paper
• Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions

  2023cites this paper
• Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy

  2023cites this paper
• Cortical neurons obtained from patient-derived iPSCs with GNAO1 p.G203R variant show altered differentiation and functional properties

  2023cites this paper
• Tsc2 coordinates neuroprogenitor differentiation

  2023cites this paper
• Cerebral vascular and blood brain–barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex

  2023cites this paper
• Neuronal APOE4-induced Early Hippocampal Network Hyperexcitability in Alzheimer’s Disease Pathogenesis

  2023cites this paper
• Rescue of Impaired Blood-Brain Barrier in Tuberous Sclerosis Complex Patient Derived Neurovascular Unit

  2023cites this paper
• GPR37L1 controls maturation and organization of cortical astrocytes during development

  2023cites this paper
• Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS Syndromes.

  2023cites this paper
• Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?

  2023cites this paper
• Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex.

  2022cites this paper
• A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway

  2022cites this paper
• The Effects of Optogenetic Activation of Astrocytes on Spike-and-Wave Discharges in Genetic Absence Epileptic Rats

  2022cites this paper
• LysM-positive neurons drive Tuberous Sclerosis Complex (TSC)-associated brain lesions.

  2022cites this paper
• Spine morphogenesis and synapse formation in tubular sclerosis complex models

  2022cites this paper
• Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex

  2022cites this paper
• GluN2C selective inhibition is a target to develop new antiepileptic compounds

  2022cites this paper
• Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice

  2022cites this paper
• NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination, and seizure threshold.

  2022cites this paper
• Current Review in Basic Science: Animal Models of Focal Cortical Dysplasia and Epilepsy

  2022cites this paper
• Modeling human neurodevelopmental diseases with brain organoids

  2022cites this paper
• Understanding the Role of Glia-Neuron Communication in the Pathophysiology of Epilepsy: A Review.

  2022cites this paper
• Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes

  2021cites this paper
• A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis

  2021cites this paper
• Tuberous Sclerosis Complex (TSC) Inactivation Increases Neuronal Network Activity by Enhancing Ca2+ Influx via L-Type Ca2+ Channels

  2021cites this paper
• Potential of Multiscale Astrocyte Imaging for Revealing Mechanisms Underlying Neurodevelopmental Disorders

  2021cites this paper
• Effects of Mutations in TSC Genes on Neurodevelopment and Synaptic Transmission

  2021cites this paper
• Altered Protein Profiles During Epileptogenesis in the Pilocarpine Mouse Model of Temporal Lobe Epilepsy

  2021cites this paper
• Astrocytes in rare neurological conditions: Morphological and functional considerations

  2021cites this paper
• Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress

  2021cites this paper
• Conditional knockout of Tsc1 in RORγt-expressing cells induces brain damage and early death in mice

  2021cites this paper
• NPRL3: Direct Effects on Human Phenotypic Variability, mTOR Signaling, Subcellular mTOR Localization, Cortical Lamination, and Seizure Susceptibility

  2020cites this paper
• Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex.

  2020cites this paper
• Neurons and Plasticity: What Do Glial Cells Have to Do with This?

  2020cites this paper
• Developing precision treatments for epilepsy using patient and animal models

  2020cites this paper
• The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective

  2020cites this paper
• mTORopathies: A Road Well-Traveled

  2020cites this paper
• A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma

  2020cites this paper
• Modeling neurological disorders using brain organoids.

  2020cites this paper
• Discovery of a Brain Penetrant ATP-competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS disorders.

  2020cites this paper
• Ornithine Decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.

  2020cites this paper
• Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.

  2020cites this paper
• Microglial mTOR is Neuronal Protective and Antiepileptogenic in the Pilocarpine Model of Temporal Lobe Epilepsy

  2020influential citation
• Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis

  2020cites this paper
• Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex

  2020cites this paper
• Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression

  2020cites this paper
• The mTOR pathway as a therapeutic target for precision medicine

  2019cites this paper
• Relationships between Astrocytes and Absence Epilepsy in Rat: An Experimental study.

  2019cites this paper
• Biallelic Mutations in TSC2 Lead to Abnormalities Associated with Cortical Tubers in Human iPSC-Derived Neurons

  2019cites this paper
• Different Responses to a High-Fat Diet in IL-6 Conditional Knockout Mice Driven by Constitutive GFAP-Cre and Synapsin 1-Cre Expression

  2019cites this paper
• Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex.

  2019cites this paper
• The Astrocyte-Neuron Interface: An Overview on Molecular and Cellular Dynamics Controlling Formation and Maintenance of the Tripartite Synapse.

  2019cites this paper
• Return of function after CNS axon regeneration: Lessons from injury-responsive intrinsically photosensitive and alpha retinal ganglion cells.

  2019cites this paper
• BRAFV600E Expression in Mouse Neuroglial Progenitors Increase Neuronal Excitability, Cause Appearance of Balloon-like cells, Neuronal Mislocalization, and Inflammatory Immune response

  2019cites this paper
• Mechanistic Target of Rapamycin Pathway in Epileptic Disorders

  2019cites this paper
• Chronic activation of anti‐oxidant pathways and iron accumulation in epileptogenic malformations

  2019cites this paper
• The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex

  2019cites this paper
• Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders

  2019cites this paper
• Astrocyte redox imbalance underlies prelimbic neuronal hypoactivity and affective behavior in epilepsy

  2019cites this paper
• Neuron–glia interactions in the pathophysiology of epilepsy

  2019cites this paper
• PTEN negatively regulates the cell lineage progression from NG2+ glial progenitor to oligodendrocyte via mTOR-independent signaling

  2018cites this paper
• Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR‐mediated etiologies

  2018cites this paper
• Astrocytes: Stars of the Sacred Disease

  2018cites this paper
• The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex

  2018influential citation
• Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex

  2018cites this paper
• Abnormal mTOR Activation in Autism.

  2018cites this paper
• Efficacy and Safety Profile of Cannabinoid-targeted Compounds for Seizure Control in Immature Animals

  2018cites this paper
• RNA Polymerase 1 Is Transiently Regulated by Seizures and Plays a Role in a Pharmacological Kindling Model of Epilepsy

  2018cites this paper
• miR147b: A novel key regulator of interleukin 1 beta‐mediated inflammation in human astrocytes

  2018cites this paper
• Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex

  2017influential citation
• RHEB1 insufficiency in aged male mice is associated with stress-induced seizures

  2017cites this paper
• Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder

  2017cites this paper
• mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells

  2017cites this paper
• Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation.

  2017cites this paper
• Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling

  2017cites this paper
• Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin

  2017cites this paper
• Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy

  2017influential citation
• Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

  2017cites this paper